{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "SEK", "marketState": "POSTPOST", "regularMarketChangePercent": -86.0404, "regularMarketPrice": 0.48995, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.596, "sharesOutstanding": 71388600, "bookValue": 0.12, "fiftyDayAverage": 0.549975, "fiftyDayAverageChange": -0.060024977, "fiftyDayAverageChangePercent": -0.10914129, "twoHundredDayAverage": 0.549975, "twoHundredDayAverageChange": -0.060024977, "twoHundredDayAverageChangePercent": -0.10914129, "marketCap": 348402, "priceToBook": 4.0829167, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "exchange": "LSE", "shortName": "ALLIGATOR BIOSCIENCE AB ALLIGAT", "longName": "Alligator Bioscience AB (publ)", "messageBoardId": "finmb_3206363", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1682665200000, "priceHint": 4, "regularMarketChange": -3.01982, "regularMarketTime": 1683650682, "regularMarketDayHigh": 0.0, "regularMarketDayRange": "0.0 - 0.0", "regularMarketDayLow": 0.0, "regularMarketVolume": 400000, "regularMarketPreviousClose": 3.50977, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "LSE", "financialCurrency": "SEK", "regularMarketOpen": 0.0, "averageDailyVolume3Month": 13751, "averageDailyVolume10Day": 13751, "fiftyTwoWeekLowChange": 0.48995, "fiftyTwoWeekRange": "0.0 - 0.621", "fiftyTwoWeekHighChange": -0.13104999, "fiftyTwoWeekHighChangePercent": -0.21103059, "fiftyTwoWeekLow": 0.0, "fiftyTwoWeekHigh": 0.621, "trailingAnnualDividendRate": 0.0, "symbol": "0RK9.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Medicon Village", "address2": "ScheelevAegen 2", "city": "Lund", "zip": "223 81", "country": "Sweden", "phone": "46 4 65 40 82 00", "website": "https://www.alligatorbioscience.se", "industry": "", "sector": "", "longBusinessSummary": "Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Sweden. The company's product portfolio includes Mitazalimab, an agonistic antibody that targets CD40, which is in phase 2 clinical trail for the treatment solid metastatic tumors, initially pancreatic cancer; and ATOR-4066, a bispecific antibody tumor-specific immune effect, developed using Neo-X-Prime technology platform for immunotherapy, which is in preclinical stage. It also offers ATOR-1017, a 4-1BB for solid metastatic tumors which is in Phase 1 clinical trial; and ALG.APV-527, which is in phase 2 clinical trail drug that target tumor-associated antigen 4-1BB and 5T4. In addition, the company develops products using its technology platforms, including ALLIGATOR-GOLD and ALLIGATOR-FAB, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; FIND, a molecular evolution technology for optimization of antibodies and other proteins; and RUBY, a bispecific antibody format. Further, it has collaboration and out-licensing agreements with Aptevo Therapeutics, Inc.; Orion Corporation.; MacroGenics, Inc.; Biotheus; and Abclon. The company was incorporated in 2000 and is headquartered in Lund, Sweden.", "fullTimeEmployees": 58, "companyOfficers": [{"maxAge": 1, "name": "Mr. S\u00f8ren  Bregenholt Ph.D.", "age": 51, "title": "Chief Exec. Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 4400000, "fmt": "4.4M", "longFmt": "4,400,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marie  Svensson", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Malin  Carlsson", "age": 54, "title": "Head of R&D, Exec. VP & COO", "yearBorn": 1968, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Laura  von Schantz", "age": 40, "title": "Chief Technology Officer", "yearBorn": 1982, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peter  Ellmark Ph.D.", "age": 49, "title": "Chief Scientific Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Julie  Silber", "title": "Director of Communications & Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sumeet  Ambarkhane M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}